Arbutus Biopharma Stock Price (NASDAQ:ABUS)

Add to My Stocks
$2.7 $0 (0%) ABUS stock closing price Feb 21, 2017 (Closing)
Arbutus Biopharma
21 FEB 2017
amigobulls logo
ABUS hand_up
ABUS vs S&P 500
Closing Price: Feb 21, 2017
$2.7 ( 0%)
S&P 500
2365.4 ( 0.6%)
52 Week Price Range
1 Year Return: -15.89%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Arbutus Biopharma Snapshot Video

11 5 2

ABUS Stock Details

Prev Close* : $2.70
Market Cap:
Day Low: $2.7
52 Week Low: $2.35
Open: $2.7
Volume: 41684
Day High: $2.75
52 Week High: $5.48

Latest Stock Market News

Latest Articles

Arbutus Biopharma News - From Partners

ABUS Stockcharts

View ABUS PE ratio, PS ratio stocks charts and compare with peers.
ABUS Chart
Note: Compare Arbutus Biopharma stock price history with the index and industry peers.

Arbutus Biopharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Arbutus Biopharma Financial Ratios

Asset Turnover
Receivables Turnover

ABUS Industry Peers

Company Price Change (%)
Mirati Therapeutics (MRTX)6.150.05 (0.81%)
Xenon Pharma (XENE)8.250.05 (0.6%)
Alnylam Pharma (ALNY)46.861.42 (2.94%)
Dicerna Pharma (DRNA)2.960.05 (1.72%)
Arrowhead Pharma (ARWR)2.150.02 (0.92%)
Marina Biotech (MRNA)0.170.01 (5.56%)
Benitec Biopharma (BNTC)2.680.37 (12.13%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
EXACT Sciences (EXAS)22.412.5 (12.56%)
Fate Therapeutics (FATE)4.380.45 (11.45%)
Nymox Pharmaceutical (NYMX)3.540.12 (3.51%)
Myriad Genetics (MYGN)19.080.46 (2.47%)
Stemline Therapeutics (STML)6.950.15 (2.21%)
Evogene (EVGN)5.4210.11 (2.07%)
OncoMed Pharma (OMED)8.910.18 (2.06%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Trevena (TRVN)4.272.86 (40.11%)
Momenta Pharma (MNTA)16.052.95 (15.53%)
Peregrine Pharma (PPHM)0.4790.07 (12.73%)
Cytokinetics (CYTK)10.40.85 (7.56%)
Argos Therapeutics (ARGS)4.40.3 (6.38%)
Sorrento Therapeutics (SRNE)5.250.3 (5.41%)
Immunomedics (IMMU)5.060.28 (5.24%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Arbutus Biopharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues24.87M14.95M15.46M14.1M16.84M
Net Income-61.12M-38.83M-14.06M29.79M-10.05M
Total Operating Expense127.18M47.91M27.6M27.02M27.49M
view Arbutus Biopharma Corp income statement
balance sheet20152014201320122011
Total Assets712.29M118.17M71.71M52.32M14.15M
Total Liabilities164.61M30.14M12.52M11.61M8.78M
Shareholders Equity547.67M88.03M59.19M40.71M5.37M
view Arbutus Biopharma Corp balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities-14.63M16.51M2.29M-2.43M1.14M
Net Cash From (Used By) Operating Activities-54.78M-12.42M-6.73M33.11M-7.77M
Increase (Decrease) In Prop Plant And Equipment-2.28M-0.97M-0.72M-0.01M-0.06M
view Arbutus Biopharma Corp cashflow statement

Arbutus Biopharma Corp Stock News - Partner Headlines

Arbutus Biopharma Stock Message Board

Arbutus Biopharma stock price ended the last trading day at 2.7. Looking at Arbutus Biopharma market capitalization, which currently stands at 148.07M, we can say that ABUS stock is a Micro cap stock. Arbutus Biopharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy ABUS stock than sell it, then Arbutus Biopharma stock price goes up. Conversely, if more investors wanted to sell ABUS stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 49633 on the last trading day, as is evident from Arbutus Biopharma stock chart, and ABUS stock quote data. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Arbutus Biopharma does not pay dividends. Arbutus Biopharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.